Repositorio Dspace

Listar por tema "Salvage Therapy"

Listar por tema "Salvage Therapy"

Ordenar por:Orden:Resultados:

  • Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial 
    Peñalver, Francisco-Javier; Marquez, José-Antonio; Duran, Soledad; Giraldo, Pilar; Martín, Alejandro; Montalban, Carlos; Sancho, Juan-Manuel; Ramírez, Maria-Jose; Terol, Maria-Jose; Capote, Francisco-Javier; Gutiérrez, Antonio; Sánchez, Blanca; López, Andrés; Salar, Antonio; Rodríguez-Caravaca, Gil; Canales, Miguel; Caballero, Maria-Dolores; Bello-López, José-Luis; Carbonell, Felix; Ferrer-Bordas, Secundino; Font-López, Patricia; Pérez-Persona, Ernesto; López-Guillermo, Armando; Hernández-Martín, Roberto; Mayans, José-Ramón; Palomera, Luis; Pérez-Ceballos, Elena; Queizan-Hernández, José-Antonio; Riaza-Grau, Rosalia; de-la-Cruz, Fatima; Sánchez-Salinas, Andrés (WILEY, 2019-11)
    BACKGROUND: Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. METHODS: This phase II trial evaluated the efficacy ...
  • Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO 
    Gutiérrez, Antonio; Zeberio, Izaskun; Peñalver, Francisco-Javier; Martínez-Barranco, Pilar; Pérez, Sandra; Morillo, Daniel; Martin, Xabier; Nicolás, Concepción; Ferrero, Ainara; Jiménez-Ubieto, Ana; Bastos-Oreiro, Mariana; Dávila-Valls, Julio; Calle, María-Victoria; Pérez, María; Rodríguez, Guillermo; Alonso, Aranzazu; García-Noblejas, Ana; Sánchez-Argüello, Diana; Knight, Teresa; Fernández, Ángeles; López, Javier; Pérez-de-Oteyza, Jaime; González-de-Villambrosia, Sonia; Pérez, Elena; Marín, Alejandro; Navarro, María-Belén; Fernández, Rubén; Gómez, Pilar; Hueso, José-Antonio; Peñarrubia-Ponce, María-Jesús; Bravo, Pilar; García-Belmonte, Daniel; de-la-Nuez, Haridian; Nistal, Sara; Abrisqueta, Pau; Iban, Fernanda; Palomera, Luis; Donato, Eva; Provencio, Andrea; Infante, María-Stefania; González-Barca, Eva (ELSEVIER, 2025-10-14)
    Relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) remains challenging to treat, especially in patients ineligible for intensive therapy or chimeric antigen receptor T cells. Tafasitamab plus lenalidomide (T/L) ...